ArticleCancer immunology research2016

Preserved Activity of CD20-Specific Chimeric Antigen Receptor-Expressing T Cells in the Presence of Rituximab.

Gregory A Rufener et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.